Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: Randomised placebo-controlled double-blind trial

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Bradshaw, Catriona S ^a,b,c   Pirotta, Marie ^d   de Guingand, Deborah ^a   Hocking, Jane S ^a,d   Morton, Anna N ^b   Garland, Suzanne M ^d,e,f   Fehler, Glenda ^b   Morrow, Andrea ^a   Walker, Sandra ^a   Vodstrcil, Lenka A ^a   Fairley, Christopher K ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; ESTRIOL; FLUCONAZOLE; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; AGENTS USED INTRAVAGINALLY; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BODY RASH; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; GENITAL HERPES; GENITAL TRACT INFECTION; HUMAN; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; METALLIC TASTE; NAUSEA; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SELF REPORT; SIDE EFFECT; TASTE; URINARY TRACT INFECTION; VAGINA DISCHARGE; VAGINA FLORA; VAGINA PAIN; VAGINA SMEAR; VAGINAL PRURITUS; VAGINITIS; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; INTRAVAGINAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; STATISTICS; TIME; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); LACTOBACILLUS ACIDOPHILUS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICATION ADHERENCE; METRONIDAZOLE; MIDDLE AGED; PLACEBOS; PROBIOTICS; RECURRENCE; SELF REPORT; TIME FACTORS; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84859235750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034540     Document Type: Article

References (26)

1. Allsworth JE, Peipert JF, (2007) Prevalence of bacterial vaginosis: 2001-2004 national health and nutrition examination survey data. Obstet Gynecol 109: 114-120.
2. Koumans EH, Markowitz LE, Hogan V, (2002) Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 35: S152-172.
3. Oduyebo OO, Anorlu RI, Ogunsola FT, (2009) The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev pp. CD006055.
4. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, et al. (2006) High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases 193: 1478-1489.
5. Senok AC, Verstraelen H, Temmerman M, Botta GA, (2009) Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev pp. CD006289.
6. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, et al. (2005) The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. Bjog 112: 234-240.
7. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, et al. (1996) Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 46: 68-73.
8. Shoubnikova M, Hellberg D, Nilsson S, Mardh PA, (1997) Contraceptive use in women with bacterial vaginosis. Contraception 55: 355-358.
9. Calzolari E, Masciangelo R, Milite V, Verteramo R, (2000) Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70: 341-346.
10. Bradshaw CS, Morton AN, Garland SM, Morris MB, Moss LM, et al. (2005) Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 106: 105-114.
11. Veres S, Miller L, Burington B, (2004) A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol 104: 555-563.
12. Nelson DB, Bellamy S, Gray TS, Nachamkin I, (2003) Self-collected versus provider-collected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability. J Clin Epidemiol 56: 862-866.
13. Strauss RA, Eucker B, Savitz DA, Thorp JM Jr, (2005) Diagnosis of bacterial vaginosis from self-obtained vaginal swabs. Infect Dis Obstet Gynecol 13: 31-35.
14. Austin MN, Beigi RH, Meyn LA, Hillier SL, (2005) Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43: 4492-4497.
15. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL, (2004) Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191: 1124-1129.
16. Nyirjesy P, McIntosh MJ, Steinmetz JI, Schumacher RJ, Joffrion JL, (2007) The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis. Sex Transm Dis 34: 197-202.
17. Meltzer MC, Desmond RA, Schwebke JR, (2008) Association of Mobiluncus curtisii with recurrence of bacterial vaginosis. Sex Transm Dis 35: 611-613.
18. Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, et al. (2002) Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 93: 884-893.
19. Velraeds MM, van de Belt-Gritter B, van der Mei HC, Reid G, Busscher HJ, (1998) Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 47: 1081-1085.
20. Barrons R, Tassone D, (2008) Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther 30: 453-468.
21. Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, et al. (2001) Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 185: 375-379.
22. Larsson PG, Brandsborg E, Forsum U, Pendharkar S, Andersen KK, et al. (2011) Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis 11: 223.
23. Vasquez A, Jakobsson T, Ahrne S, Forsum U, Molin G, (2002) Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 40: 2746-2749.
24. Ya W, Reifer C, Miller LE, (2010) Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 203: 120 e121-126.
25. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, et al. (2009) Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis 36: 564-569.
26. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, et al. (2010) Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 37: 745-750.